View in EDS

452PD - Safety, antitumor activity, and pharmacokinetics (PK) of pamiparib (BGB-290), a PARP1/2 inhibitor, in patients (pts) with advanced solid tumours: Updated phase I dose-escalation/expansion results.

Saved in:
Bibliographic Details
Title: 452PD - Safety, antitumor activity, and pharmacokinetics (PK) of pamiparib (BGB-290), a PARP1/2 inhibitor, in patients (pts) with advanced solid tumours: Updated phase I dose-escalation/expansion results.
Authors: Voskoboynik, M.1 (AUTHOR), Mileshkin, L.2 (AUTHOR), Gan, H.3 (AUTHOR), Millward, M.4 (AUTHOR), Au-Yeung, G.2 (AUTHOR), Meniawy, T.M.4 (AUTHOR), Kichenadasse, G.5 (AUTHOR), Zhang, K.6 (AUTHOR), Zhang, M.7 (AUTHOR), Mu, S.8 (AUTHOR), Lickliter, J.D.1 (AUTHOR)
Source: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv167-v167. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152683094
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 452PD - Safety, antitumor activity, and pharmacokinetics (PK) of pamiparib (BGB-290), a PARP1/2 inhibitor, in patients (pts) with advanced solid tumours: Updated phase I dose-escalation/expansion results.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Voskoboynik%2C+M%2E%22">Voskoboynik, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mileshkin%2C+L%2E%22">Mileshkin, L.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gan%2C+H%2E%22">Gan, H.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Millward%2C+M%2E%22">Millward, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Au-Yeung%2C+G%2E%22">Au-Yeung, G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meniawy%2C+T%2EM%2E%22">Meniawy, T.M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kichenadasse%2C+G%2E%22">Kichenadasse, G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+K%2E%22">Zhang, K.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+M%2E%22">Zhang, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mu%2C+S%2E%22">Mu, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lickliter%2C+J%2ED%2E%22">Lickliter, J.D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2019 Supplement 6, Vol. 30, pv167-v167. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152683094
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdz244.014
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: v167
    Titles:
      – TitleFull: 452PD - Safety, antitumor activity, and pharmacokinetics (PK) of pamiparib (BGB-290), a PARP1/2 inhibitor, in patients (pts) with advanced solid tumours: Updated phase I dose-escalation/expansion results.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Voskoboynik, M.
      – PersonEntity:
          Name:
            NameFull: Mileshkin, L.
      – PersonEntity:
          Name:
            NameFull: Gan, H.
      – PersonEntity:
          Name:
            NameFull: Millward, M.
      – PersonEntity:
          Name:
            NameFull: Au-Yeung, G.
      – PersonEntity:
          Name:
            NameFull: Meniawy, T.M.
      – PersonEntity:
          Name:
            NameFull: Kichenadasse, G.
      – PersonEntity:
          Name:
            NameFull: Zhang, K.
      – PersonEntity:
          Name:
            NameFull: Zhang, M.
      – PersonEntity:
          Name:
            NameFull: Mu, S.
      – PersonEntity:
          Name:
            NameFull: Lickliter, J.D.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 2019 Supplement 6
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 30
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1